These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 4200675

  • 1. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A, Mariani MM, Ribes G, Alric R.
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract] [Full Text] [Related]

  • 2. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A, Ribes G, Mariani MM, Alric R.
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract] [Full Text] [Related]

  • 3. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J, Cordes U, Sell G, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract] [Full Text] [Related]

  • 4. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E, Garcia RV, Barberia Layana JJ, Morant Ciscard JA, Calleja Canelas A.
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
    [No Abstract] [Full Text] [Related]

  • 5. Glipizide: experimental study and comparison with other sulfonylureas.
    Loubatieres-Mariani MM.
    Acta Endocrinol Suppl (Copenh); 1980 Jan; 239():26-32. PubMed ID: 6776761
    [No Abstract] [Full Text] [Related]

  • 6. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
    Beyer J, Cordes U, Sell G, Krall H, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J, Haupt E, Cordes U, Sell G, Schöffling K.
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract] [Full Text] [Related]

  • 8. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J, Gather W, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract] [Full Text] [Related]

  • 9. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E, Beyer J, Schöffling K.
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract] [Full Text] [Related]

  • 10. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A.
    Drugs; 1971 Mar; 1(2):109-15. PubMed ID: 4999930
    [No Abstract] [Full Text] [Related]

  • 11. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I, Madsen SN.
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract] [Full Text] [Related]

  • 12. Proceedings: Half-life of phenprocoumarol (Marcumar R) during treatment with insulin and sulfonylureas in diabetics.
    Heine P, Kewitz H, Wiegboldt KA.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 May; 282(Suppl):suppl 282:R30. PubMed ID: 4276557
    [No Abstract] [Full Text] [Related]

  • 13. [Differential therapy using oral antidiabetics].
    Mehnert H.
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the effect of tolbutamide, glibenclamide, HB 699, and glucose on serum insulin and blood glucose in gastro-enterectomized dogs.
    Bickel M, Geisen K, Schleyerbach R.
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):118-38. PubMed ID: 101159
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H, Denes A, Girard J, Collard F, Berger W.
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract] [Full Text] [Related]

  • 17. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
    Lorch E, Gey KF, Sommer P.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
    [No Abstract] [Full Text] [Related]

  • 18. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J, Haupt E, Cordes U, Kutschera J, Schöffling K.
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract] [Full Text] [Related]

  • 19. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB.
    Journ Annu Diabetol Hotel Dieu; 1984 Jan; ():183-91. PubMed ID: 6443219
    [No Abstract] [Full Text] [Related]

  • 20. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD.
    Clin Pharm; 1984 Jan; 3(5):473-85. PubMed ID: 6435940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.